Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
A targeted new drug for a rare and aggressive form of lung cancer will be […]
Evusheld Approved to Prevent COVID-19 in People Whose Immune Response is Poor
A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines […]
England to Return to Plan A Following the Success of the Booster Programme
The government has today announced that England will fully return to Plan A on Thursday […]
NHS Launches Landmark Mental Health Campaign With ‘Help!’ From The Beatles
Today, the NHS will launch a new landmark campaign using the iconic Beatles song ‘Help!” […]
Government Sets Clear Ambition to Close Gender Health Gap
Decades of gender health inequality will be addressed as the government publishes its vision to […]
UK's Most Vulnerable People to Receive Life-saving COVID-19 Treatments in the Community
Thousands of the UK’s most vulnerable people will be among the first in the world to […]
Government to Invest £375 Million in Neurodegenerative Disease Research
People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, […]
Lateral Flow Tests to be Introduced for Vaccinated International Arrivals
Eligible fully vaccinated passengers arriving in England from countries not on the red list can […]
Health Secretary has Genome Sequenced for Project Tackling Health Disparities
Health and Social Care Secretary Sajid Javid visited Great Ormond Street Hospital today to provide […]
New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems
A new clinical trial to determine whether a third dose of vaccine will improve the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more